Tandem Diabetes Care, manufacturer of the t:slim, t:slim G4 and t:flex Insulin Pumps, has gotten U.S. Food and Drug Administration (FDA) clearance of the Tandem Device Updater, a Mac and PC-compatible tool for the remote update of Tandem insulin pump software.
“It’s a way to deliver ongoing innovation to our customers faster than the industry has been able to in the past, which is of particular significance as our artificial pancreas efforts accelerate,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care.
The first use of the Tandem Device Updater will be for deployment of the latest t:slim Insulin Pump software to in-warranty t:slim Pumps purchased before April 2015. This updated software began shipping on new t:slim Pumps as of April 2015 and includes a variety of product enhancements for convenience and flexibility. Future software improvements and enhancements will be implemented through the Tandem Device Updater as they are cleared for commercial distribution.
Tandem Diabetes Care intends to roll out the Tandem Device Updater first to early t:slim Pump users throughout the summer in a series of test groups, followed by an expanded launch later this year.